ArticleAnti-cancer agents in medicinal chemistry2024

A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated 'Orphan Drug', for the Treatment of Hepatocellular Carcinoma.

Chenicheri Kizhakkeveettil Keerthana et al.PubMed ↗Publisher ↗

No numbers read from the abstract.